ADC Therapeutics S.A.

ADCT· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$1.05-0.47%

2026-09-18

Financials

Valuation Metrics

ADC Therapeutics S.A.'s Market Cap is $134M. At end of 2025 it was $531M. Ranked #3064 of 3,121 in US market (top 98%), #1649 of 1,658 on NYSE (top 99%), #262 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 98%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$134M	US#3,064/3,121 Sec#262/266
Revenue	$79M	US#2,735/3,121 Sec#133/266
Net Income	$-97M	US—/3,121 Sec—/266
Total Assets	$279M	US#2,935/3,121 Sec#219/266
Net Assets	$-228M	US#2,996/3,121 Sec#261/266
Value
P/S	1.70x	US#1,139/3,121 Sec#20/266
FCF Yield	-76.25%	US—/3,121 Sec—/266
Profitability
ROA	-34.69%	US#2,918/3,121 Sec#171/266
Op. Margin	-125.83%	US#2,751/3,121 Sec#129/266
Revenue Growth	1.97%	US#2,090/3,121 Sec#126/266
Financial Health
Total Debt	$417M	US#1,966/3,121 Sec#67/266
FCF	$-102M	US#2,631/3,121 Sec#144/266
Cash	$219M	US#1,666/3,121 Sec#104/266
Current Ratio	3.03x	US#785/3,121 Sec#192/266
Performance
1Y Return	-68.88%	US#3,059/3,121 Sec#257/266
1M Return	1.44%	US#720/3,121 Sec#74/266
From 52W High	-78.82%	US#3,073/3,121 Sec#258/266
1Y MDD	-80.33%	US#3,068/3,121 Sec#257/266
Trading
Volume	924,436 shares	US#1,066/3,121 Sec#107/266
Trading Value	$998390.00	US#2,956/3,121 Sec#252/266
Per Share
EPS	$-0.76	US—/3,121 Sec—/266
BPS	$-1.79	US—/3,121 Sec—/266